secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viking Therapeutics, Inc. (VKTX)
CIK:        0001607678
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0000950170-25-057323
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viking Therapeutics appoints CBIZ as independent auditor after Marcum resignation
--------------------------------------------------------------------------------

- Marcum resigned April 18, 2025, after CBIZ acquired its attest business.
- Audit committee appointed CBIZ as auditor for FY2025 on April 22, 2025.
- No disagreements or reportable events with Marcum in FY2023 or FY2024.
- Company will file revised proxy for May 20, 2025 annual meeting to reflect CBIZ in Proposal 2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607678/000095017025057323/0000950170-25-057323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607678/000095017025057323/vktx-20250418.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-057323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer